FundingWatcher
Home / Startups / Top health care startups / Health care startups in Massachusetts, United States

Health care startups in Massachusetts, United States

Updated 16 Nov 2026

Reset
Health care startups in Massachusetts, United States
One-time CSV
  • 1,220 funded companies, 1,055 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~massachusetts-united-states.csv1,220 rows × 18 columns
CompanyCityLast roundAmountDate
Insilico MedicineCambridgeSeries E$123.0M2025-03-13
Ratio TherapeuticsBostonSeries C$70.0M2026-07-31
TraceLinkNorth ReadingSeries D$93.0M2018-08-21
WHOOPBostonSeries G$575.0M2026-03-31
Iterative HealthCambridgeSeries C$77.0M2026-04-30
PhaseVBostonSeries A$50.0M2025-05-13
OriginBostonSeries B$56.0M2021-08-30
VideaHealthBostonSeries B$40.0M2025-01-28

8 rows of the CSV in 5 of its 18 columns.

1,220
Startups
$54.7B
Total raised
155
Funded in the last 12 months
$5.1B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 1,220
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Cambridge Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
Alzheon Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. Biotech Framingham Series F $78.8M 2026-09-10 $343.3M Ally Bridge Group, National Institute on Aging 11 to 50 2013
INIA Biosciences INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. Biotech Boston Seed $1.5M 2026-09-08 $1.5M MassChallenge, MedTech Innovator 1 to 10 2020
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Boston Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Cambridge Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
Remedium Bio Remedium Bio develops gene therapy treatments for various diseases. Biotech Needham Series A $10.0M 2026-08-10 $13.8M National Science Foundation, MicroVentures, Longevitytech.fund +1 11 to 50 2020
Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Boston Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Boston Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021
InStockRx InStockRx connects licensed pharmacies to buy and sell inventory with each other. Commerce Boston Series A $5.0M 2026-07-01 $5.1M Techstars 1 to 10 2020
Xellar Biosystems Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. Artificial intelligence Newton Series A $29.5M 2026-06-30 $93.2M Legend Capital, Tiantu Capital, Zhengxuan Investment +1 11 to 50 2022
Cartwheel Cartwheel makes first aid products for families, starting with head lice treatments. Health care Boston Seed $557K 2026-06-25 $557K Health Wildcatters 1 to 10 2023
Portal Portal engineers cells to develop new treatments and therapies. Biotech Watertown Seed $9.0M 2026-06-18 $25.7M Pear VC, Page One Ventures, IA Ventures +2 11 to 50 2023
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
InStride Health InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. Health care Boston Series C $30.0M 2026-06-15 $86.0M General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 251 to 500 2021
CereVasc CereVasc develops a minimally invasive treatment for communicating hydrocephalus. Biotech Charlestown Series C $85.0M 2026-06-04 $199.0M Perceptive Advisors, Bain Capital Life Sciences, ATON Partners 11 to 50 2014
Cerevance Cerevance develops novel therapeutics for neurological diseases. Biotech Boston Series C $20.0M 2026-05-12 $209.5M Google Ventures, Casdin Capital, Foresite Capital +1 51 to 100 2016
Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Cambridge Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
AcuityMD AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. Artificial intelligence Boston Series C $80.0M 2026-04-21 $163.0M Redpoint, Benchmark, ICONIQ Growth +2 251 to 500 2019
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Cambridge Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Beacon Biosignals Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. Artificial intelligence Boston Series B $11.0M 2026-04-06 $127.0M General Catalyst, Half Court Ventures, Indicator Ventures +1 101 to 250 2019
WHOOP Unicorn WHOOP sells wearable fitness devices and a subscription service that tracks physiological data for performance insights. Hardware Boston Series G $575.0M 2026-03-31 $979.8M Founder Collective, SoftBank Vision Fund, Foundry Group +2 501 to 1,000 2012
EnVision Endoscopy EnVision Endoscopy supplies medical devices and solutions used in endoscopic surgeries. Health care Lowell Series A $500K 2026-03-30 $3.9M MassChallenge, National Science Foundation, MassVentures +1 1 to 10 2018
Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Cambridge Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
Flourish Care Flourish Care provides childbirth education, birth planning, and newborn care services. Commerce Boston Seed $5.7M 2026-03-18 $5.7M MassChallenge, Texas HALO Fund 11 to 50 2020
Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Cambridge Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Cambridge Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
Coral Care Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. Health care Boston Series A $13.0M 2026-02-23 $19.5M Hustle Fund, Reach Capital, AlleyCorp +2 11 to 50 2023
Gelmedix Gelmedix develops a biomaterial platform that improves drug delivery for complex eye treatments. Biotech Newton Seed $13.0M 2026-02-17 $15.4M Safar Partners, EQx Fund, HTL Innovations 1 to 10 2020
Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Boston Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022

Table 1. Health care startups in Massachusetts, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,220.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 WHOOP Unicorn WHOOP sells wearable fitness devices and a subscription service that tracks physiological data for performance insights. Hardware Boston Series G $575.0M 2026-03-31 $979.8M Founder Collective, SoftBank Vision Fund, Foundry Group +2 501 to 1,000 2012
2 Diagonal Therapeutics Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. Biotech Watertown Series B $125.0M 2026-01-08 $253.0M Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 11 to 50 2022
3 Sanegene Bio Sanegene Bio develops an RNAi drug discovery platform aimed at unmet clinical needs. Biotech Woburn Series B $110.0M 2025-12-08 $240.0M Shenzhen Capital Group, Qiming Venture Partners, Northern Light Venture Capital +1 51 to 100 2021
4 Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Cambridge Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
5 Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
6 CereVasc CereVasc develops a minimally invasive treatment for communicating hydrocephalus. Biotech Charlestown Series C $85.0M 2026-06-04 $199.0M Perceptive Advisors, Bain Capital Life Sciences, ATON Partners 11 to 50 2014
7 AcuityMD AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. Artificial intelligence Boston Series C $80.0M 2026-04-21 $163.0M Redpoint, Benchmark, ICONIQ Growth +2 251 to 500 2019
8 Alzheon Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. Biotech Framingham Series F $78.8M 2026-09-10 $343.3M Ally Bridge Group, National Institute on Aging 11 to 50 2013
9 Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Cambridge Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
10 Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Boston Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021

Table 2. Health care startups in Massachusetts, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 MassChallenge Startup accelerator Boston, United States 28 2% 4 INIA Biosciences, EnVision Endoscopy, Flourish Care
2 Techstars Startup accelerator New York, United States 17 1% 1 InStockRx
3 RA Capital Management Startup incubator Boston, United States 14 1% 4 Delix Therapeutics, Superluminal Medicines, Terrestrial Bio
4 Alumni Ventures Angel group Manchester, United States 13 1% 1 Iterative Health
5 National Science Foundation Entrepreneurship program Alexandria, United States 13 1% 4 Remedium Bio, Kytopen, EnVision Endoscopy
6 Y Combinator Startup accelerator Mountain View, United States 12 1% 1 Benchify
7 F-Prime Venture capital firm Cambridge, United States 11 1% 1 Nocion Therapeutics
8 Google Ventures Corporate venture arm San Francisco, United States 11 1% 1 Cerevance
9 Polaris Partners Private equity firm Boston, United States 10 1% 1 Triveni Bio
10 MassVentures Venture capital firm Boston, United States 10 1% 2 Kytopen, EnVision Endoscopy
11 .406 Ventures Venture capital firm Boston, United States 8 1% 2 InStride Health, FamilyWell Health
12 Invus Private equity firm New York, United States 8 1% 1 Triveni Bio
13 General Catalyst Venture capital firm San Francisco, United States 7 1% 2 InStride Health, Beacon Biosignals
14 Andreessen Horowitz Venture capital firm Menlo Park, United States 7 1%
15 Alexandria Venture Investments Venture capital firm Pasadena, United States 7 1% 2 Triveni Bio, Kytopen

Table 3. Health care startups in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 652 53% $43.6B
Software 290 24% $9.0B
Artificial intelligence 143 12% $5.8B
Hardware 62 5% $2.2B
Commerce 32 3% $187.8M
Fintech 20 2% $265.3M
Education 19 2% $112.5M
Energy 4 0% $4.5M
Cybersecurity 4 0% $9.8M

Table 4. Health care startups in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 88 7% $250K
Seed 461 38% $1.5M
Series A 308 25% $20.0M
Series B 211 17% $35.2M
Series C 97 8% $37.0M
Series D+ 55 5% $36.5M

Table 5. Health care startups in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Boston 438 36%
Cambridge 354 29%
Waltham 49 4%
Watertown 31 3%
Newton 26 2%
Lexington 26 2%
Woburn 24 2%
Somerville 18 1%
Burlington 13 1%
Natick 13 1%
Framingham 12 1%
Andover 11 1%

Table 6. Health care startups in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 7 5% $177.3M
October 2026 7 5% $342.3M
September 2026 15 10% $503.1M
August 2026 16 10% $478.7M
July 2026 8 5% $151.2M
June 2026 18 12% $578.3M
May 2026 4 3% $146.8M
April 2026 14 9% $440.2M
March 2026 14 9% $917.5M
February 2026 11 7% $86.2M
January 2026 22 14% $707.0M
December 2025 13 8% $348.5M
November 2025 6 4% $210.2M

Table 7. Health care startups in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 136 11% $4.5B
2025 152 12% $4.6B
2024 107 9% $3.5B
2023 107 9% $4.4B
2022 128 10% $3.5B
2021 117 10% $3.4B

Table 8. Health care startups in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 150 12%
2020 to 2022 262 22%
2015 to 2019 402 33%
2010 to 2014 209 17%
Before 2010 179 15%

Table 9. Health care startups in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 452 38%
11 to 50 517 43%
51 to 100 110 9%
101 to 250 72 6%
251 to 500 22 2%
501 to 1,000 12 1%
1,001 to 5,000 3 0%
5,001 to 10,000 2 0%
10,001 or more 2 0%

Table 10. Health care startups in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Massachusetts, United States are on the list?
1,220, in the file dated 16 November 2026. 155 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 1,220 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in Massachusetts, United States: 1,220 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care startups in Massachusetts, United States by funding stage

Other sectors in Massachusetts

Health care startups elsewhere

Cite: FundingWatcher, 1,220 funded health care companies in Massachusetts, United States, 16 November 2026. https://fundingwatcher.com/startups/health-care/massachusetts-united-states/